These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 1370354
1. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Resnitzky D, Tiefenbrun N, Berissi H, Kimchi A. Proc Natl Acad Sci U S A; 1992 Jan 01; 89(1):402-6. PubMed ID: 1370354 [Abstract] [Full Text] [Related]
2. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells. Melamed D, Tiefenbrun N, Yarden A, Kimchi A. Mol Cell Biol; 1993 Sep 01; 13(9):5255-65. PubMed ID: 7689148 [Abstract] [Full Text] [Related]
3. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells. Tiefenbrun N, Kimchi A. Oncogene; 1991 Jun 01; 6(6):1001-7. PubMed ID: 1712443 [Abstract] [Full Text] [Related]
4. Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells. Resnitzky D, Kimchi A. Cell Growth Differ; 1991 Jan 01; 2(1):33-41. PubMed ID: 1706617 [Abstract] [Full Text] [Related]
5. Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway. Arany I, Rady P, Tyring SK. Antiviral Res; 1994 Feb 01; 23(2):131-41. PubMed ID: 7511881 [Abstract] [Full Text] [Related]
7. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta. Hu X, Zuckerman KS. Leuk Lymphoma; 2000 Jul 01; 38(3-4):235-46. PubMed ID: 10830731 [Abstract] [Full Text] [Related]
8. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R. Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049 [Abstract] [Full Text] [Related]
9. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
10. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Ando K, Griffin JD. Oncogene; 1995 Feb 16; 10(4):751-5. PubMed ID: 7862452 [Abstract] [Full Text] [Related]
11. Cytokine triggered molecular pathways that control cell cycle arrest. Kimchi A. J Cell Biochem; 1992 Sep 16; 50(1):1-9. PubMed ID: 1385455 [Abstract] [Full Text] [Related]
12. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10699-704. PubMed ID: 9380698 [Abstract] [Full Text] [Related]
13. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A. Cell Death Differ; 1998 May 30; 5(5):381-9. PubMed ID: 10200487 [Abstract] [Full Text] [Related]
14. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937). Vrana JA, Saunders AM, Chellappan SP, Grant S. Differentiation; 1998 May 30; 63(1):33-42. PubMed ID: 9615391 [Abstract] [Full Text] [Related]
15. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. Alevizopoulos K, Vlach J, Hennecke S, Amati B. EMBO J; 1997 Sep 01; 16(17):5322-33. PubMed ID: 9311992 [Abstract] [Full Text] [Related]
16. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Santoni-Rugiu E, Jensen MR, Thorgeirsson SS. Cancer Res; 1998 Jan 01; 58(1):123-34. PubMed ID: 9426068 [Abstract] [Full Text] [Related]
17. The retinoblastoma gene product is bound in the nucleus in early G1 phase. Stokke T, Erikstein BK, Smedshammer L, Boye E, Steen HB. Exp Cell Res; 1993 Jan 01; 204(1):147-55. PubMed ID: 8416792 [Abstract] [Full Text] [Related]
18. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. Arvanitakis L, Yaseen N, Sharma S. J Immunol; 1995 Aug 01; 155(3):1047-56. PubMed ID: 7636179 [Abstract] [Full Text] [Related]
19. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells. Hu X, Cress WD, Zhong Q, Zuckerman KS. Biochem Biophys Res Commun; 2000 Oct 05; 276(3):930-9. PubMed ID: 11027571 [Abstract] [Full Text] [Related]
20. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ. Oncogene; 1998 May 28; 16(21):2803-13. PubMed ID: 9652748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]